United States securities and exchange commission logo





                             January 29, 2024

       Timothy G. Dixon
       Chief Executive Officer
       Therapeutic Solutions International, Inc.
       701 Wild Rose Lane
       Elk City, Idaho 83525

                                                        Re: Therapeutic
Solutions International, Inc.
                                                            Registration
Statement on Form S-1
                                                            Filed January 17,
2024
                                                            File No. 333-276559

       Dear Timothy G. Dixon:

              We have conducted a limited review of your registration statement
and have the
       following comment(s).

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe a comment applies to your
facts and circumstances
       or do not believe an amendment is appropriate, please tell us why in
your response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to this letter, we may have additional comments.

       Registration Statement on Form S-1 filed January 17, 2024

       Executive Compensation, page 43

   1.                                                   Please include
executive compensation disclosure for your executive officers for the fiscal
                                                        year ended December 31,
2023. For guidance, please refer to Item 402 of Regulation S- K
                                                        and Question 117.05 of
the Compliance & Disclosure Interpretations for Regulation S-K.
               We remind you that the company and its management are
responsible for the accuracy
       and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of
       action by the staff.

              Refer to Rules 460 and 461 regarding requests for acceleration.
Please allow adequate
       time for us to review any amendment prior to the requested effective
date of the registration
       statement.

                                                        Please contact Conlon
Danberg at 202-551-4466 or Jessica Ansart at 202-551-4511 with
 Timothy G. Dixon
Therapeutic Solutions International, Inc.
January 29, 2024
Page 2

any other questions.



                                                         Sincerely,

FirstName LastNameTimothy G. Dixon                     Division of Corporation
Finance
                                                       Office of Industrial
Applications and
Comapany NameTherapeutic Solutions International, Inc.
                                                       Services
January 29, 2024 Page 2
cc:       Hugh Kelso, Esq.
FirstName LastName